EBS Central Post Trade Client Connectivity

Access the production EBS Post Trade adapters via the following three methods in all primary regions:

These adapters are part of the EBS Forward Deploy environment that supports EBS applications on CME Globex.

The below connection options are for EBS Central Post Trade in Production.

Internet Using SSL

For all connectivity, the target port is assigned by the CIS team.

Region

Access Method

Application

Client Target Address

Region

Access Method

Application

Client Target Address

NY5

Internet

EBS CPT FIX S-Tunnel

198.246.141.195

NY5

Internet

EBS CPT TOF S-Tunnel

198.246.141.196

 

LD42

Internet

EBS CPT FIX S-Tunnel

198.246.142.195

LD42

Internet

EBS CPT TOF S-Tunnel

198.246.142.196

 

TY3

Internet

EBS CPT FIX S-Tunnel

198.246.140.195

TY3

Internet

EBS CPT TOF S-Tunnel

198.246.140.196

Leased Line / Cross Connect (through RNet) Using SSL

Region

Access Method

Application

Client Target Address

Region

Access Method

Application

Client Target Address

NY5

LL/RNet

EBS CPT FIX S-Tunnel

164.74.39.133

NY5

LL/RNet

EBS CPT TOF S-Tunnel

164.74.39.134

 

LD42

LL/RNet

EBS CPT FIX S-Tunnel

164.74.79.133

LD42

LL/RNet

EBS CPT TOF S-Tunnel

164.74.79.134

 

TY3

LL/RNet

EBS CPT FIX S-Tunnel

164.74.111.133

TY3

LL/RNet

EBS CPT TOF S-Tunnel

164.74.111.134

Direct Leased Line / Cross Connect (through RNet)

For EBS CPT FIX clients, target port 8000.

EBS CPT TOF clients will be assigned a port by the CIS team in the range 5559 - 5579.

Region

Access Method

Application

Client Target Address

Region

Access Method

Application

Client Target Address

NY5

LL/RNet

EBS CPT FIX Direct-Access

164.74.39.135

NY5

LL/RNet

EBS CPT TOF Direct-Access

164.74.39.136

 

LD42

LL/RNet

EBS CPT FIX Direct-Access

164.74.79.135

LD42

LL/RNet

EBS CPT TOF Direct-Access

164.74.79.136

 

TY3

LL/RNet

EBS CPT FIX Direct-Access

164.74.111.135

TY3

LL/RNet

EBS CPT TOF Direct-Access

164.74.111.136

 




How was your Client Systems Wiki Experience? Submit Feedback

Copyright © 2024 CME Group Inc. All rights reserved.